ATAI Life Sciences AG's Form 4 filing
COMPASS Pathways plc (CMPS) · filed Sep 27, 2024
- Accession no.
- 0001140361-24-042246
- Filed
- Sep 27, 2024, 8:00 PM ET
- Trade date
- Sep 26, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $16.1M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| ATAI Life Sciences AGCIK 0001776242 | 10% Owner |
| ATAI Life Sciences N.V.CIK 0001840904 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | Ordinary Shares | SSaleDisposed | −2,660,000 | $6.05 | −$16,093,000 | 6,905,774 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.